# LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lpcat1-promotes-gefitinib-resistance-via-upregulation-of-the-egfr-pi3k-akt/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jianghua Ding,Xinjing Ding,Zhaohui Leng |
| Citations | 20 |
| DOI | 10.7150/jca.66126 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.jcancer.org/v13p1837.pdf |
| OpenAlex ID | https://openalex.org/W4225981368 |
| PMID | 35399731 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jianghua Ding](https://scholariq.org/researchers/jianghua-ding/)
- [Zhaohui Leng](https://scholariq.org/researchers/zhaohui-leng/)

## Paper primary topic

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Paper topics

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.